celecoxib has been researched along with ethyl cellulose in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chandran, S; Ravi, P; Saha, RN | 1 |
El Ghazouani, F; Homar, M; Kerc, J; Kristl, J; Maincent, P; Ubrich, N | 1 |
Bello, A; Beyerinck, R; Bloom, C; Morgen, M; Shamblin, S; Song, W; Steenwyk, R; Wilkinson, K | 1 |
3 other study(ies) available for celecoxib and ethyl cellulose
Article | Year |
---|---|
Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.
Topics: Celecoxib; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Lactose; Methylcellulose; Pyrazoles; Solubility; Sulfonamides; Tablets; Technology, Pharmaceutical | 2006 |
Influence of polymers on the bioavailability of microencapsulated celecoxib.
Topics: Administration, Oral; Animals; Biological Availability; Celecoxib; Cellulose; Chemistry, Pharmaceutical; Cyclooxygenase Inhibitors; Drug Compounding; Drug Delivery Systems; Lactose; Male; Particle Size; Polymers; Pyrazoles; Rabbits; Sulfonamides | 2007 |
Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug.
Topics: Adult; Animals; Biological Availability; Celecoxib; Cellulose; Cyclooxygenase 2 Inhibitors; Dogs; Humans; Male; Nanoparticles; Permeability; Pyrazoles; Solubility; Sulfonamides | 2012 |